Detalhe da pesquisa
1.
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med
; 388(3): 214-227, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652353
2.
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
N Engl J Med
; 386(20): 1910-1921, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320659
3.
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
Diabetes Obes Metab
; 26(6): 2412-2421, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558508
4.
EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study.
J Hepatol
; 76(3): 506-517, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34740705
5.
A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis.
Clin Gastroenterol Hepatol
; 19(12): 2670-2672, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152542
6.
Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.
J Endocr Soc
; 7(5): bvad043, 2023 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37091306
7.
Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes.
Diabetes Care
; 45(12): 2976-2981, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36181554
8.
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
Diabetes Technol Ther
; 24(2): 84-92, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515521
9.
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Nat Med
; 28(10): 2092-2099, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192552
10.
Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
J Clin Endocrinol Metab
; 104(11): 5136-5147, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31369089
11.
Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA1c: The FREEDOM-1 HBL (High Baseline) Study.
Diabetes Care
; 41(3): 613-619, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301824
12.
A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.
Diabetes Technol Ther
; 20(3): 197-206, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29381090
13.
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Nat Med
; 29(11): 2959, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932248
14.
Effect of Repeated Doses of Acetaminophen on a Continuous Glucose Monitoring System with Permselective Membrane.
J Diabetes Sci Technol
; 15(2): 517-518, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32865043
15.
Glycemic Effect and Safety of a Systemic, Partial Glucokinase Activator, PF-04937319, in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin-A Randomized, Crossover, Active-Controlled Study.
Clin Pharmacol Drug Dev
; 5(6): 517-527, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27870481
16.
A Head-to-Head Comparison Study of the First-Day Performance of Two Factory-Calibrated CGM Systems.
J Diabetes Sci Technol
; 14(2): 493-495, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31910661
17.
Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial.
Am J Med
; 126(2): 141-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23218892
18.
Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-55131